2 min read
It was wonderful to connect with so many of our peers at RAPS Convergence 2025 in Pittsburgh. As the largest annual gathering of regulatory professionals, the event brought together more than 2,000 experts across pharmaceuticals, biologics, devices, and...
1 min read
Developing treatments for neurological, psychiatric, or CNS disorders means navigating complex trial designs, subjective endpoints, and global variability, all under tight timelines. These complexities must be translated into submissions that regulators...
1 min read
Learn how our neuroscience team partner with sponsors across multiple therapeutic areas to accelerate trial success in complex neurological and psychiatric conditions. Our collaborative efforts have supported successful marketing applications,...